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THE blood content ofascitic tumours had received only fleeting attention until
1961 when the present author started to investigate the possible significance of
the blood content of the Ehrlich ascites carcinoma (Hartveit, 1961b). The
conclusion reached from these investigations was that the blood that appeared
in the tumour was a reflection of the mouse's response to the injection of homo-
logous tissue (i.e. tissue ofthe same species but ofdifferent genetic make-up from
the host). Although the tissue injected was tumour tissue, it could not be
concluded that the blood appeared in response to the injection of tumour tissue,
but only to tissue that differed genetically from the host.
In view of the present controversy as to the existence or non-existence of
tumour specific antigens, which is of fundamental importance in the field of
tumour immunity, it was felt that an attempt should be made to go deeper into
the question ofwhether the blood that appeared in response to the intraperitoneal
injection of the Ehrlich ascites carcinoma appeared because the tumour is a
homograft or because it is a tumour.
As it is notpossible to inject the Ehrlich ascites carcinoma intomice ofthe same
genetic constitution as the tumour, it was decided to study the behaviour of a
tumour of known genetic origin on injection into genetically compatible mice.
MATERIAL AND METHODS
Mice.-Mice of strain A/Sn-first obtained through the courtesy of Professor
Klein in Stockholm, and later kept by strict brother-sister mating at this Institute
-were used. First generation hybrids of these mice and mice of the closed
colony kept at this Institute (Hartveit, 1961a) were also used. The mice were
used when they were between 4 and 6 months old.
Tumour.-The tumour used arose in a breeding A/Sn female as a solid ana-
plastic mammary carcinoma (Fig. 1). As it was the fourth mammary carcinoma
to arise in this stock in Bergen it was called the Bergen A4 carcinoma, or BA4
for short.
Preparation of Tumourfor Injection
Solid tumour.-A piece ofsolid tumour was ground in a hand mortar. Physio-
logical saline was added little by little until about 9 parts ofsaline had been added
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to one part of tumour. The resulting mixture was allowed to stand for a moment
or so to allow the coarser debris to sink. The supernatant tumour-saline sus-
pension was then taken up in a syringe and injected through a No. 1 serum needle
at a dosage of 0 5 ml. per mouse.
Ascitic tumour (see below). The abdomen was opened to obtain the fluid
which was taken up directly into a syringe and injected through a No. 20 needle.
A dose of 0.1 ml. per mouse was used.
Further investigations. The mice were inspected daily for signs of tumour
growth. The survival time of all mice was also recorded. The ascitic tumour
volume and the tumour blood content were measured as described previously
(Hartveit, 1961a).
Experimental Procedure
The experimental procedure is summarised in Table I, which shows the steps
TABLE I. The Derivation of the BA4 Ascitic Tumour
SC subcutaneous transplantation.
IP intraperitoneal transplantation.
BA4 spontaneous
nammary carcinoma
($ A/Sn)
No. and Transpl. Transplant
type of mouse meth. generation
2d + 2? Fl SC 1
2d + 2$' Fl SC 2
5.i +5Y Fl SC
Fl IP 3
IS10 1,3101S1, 5$?
Source of BA4 ascitic tumour.
taken to obtain an ascitic tumour from the original solid BA4. Firstly the solid
tumour was carried subcutaneously for two transplant generations in the Fl
hybrids described above. Tumour from the second transplant generation was
then transplanted subcutaneously to further Fl hybrids. At the same time the
tumour was transplanted intraperitoneally into 5 male and 5 female Fl hybrids.
As will be described below, a haemorrhagic exudate with many free tumour
cells developed in one of these male mice (Fig. 2). This mouse was the source of
the BA4 ascitic tumour. The exudate from this mouse was transplanted further,
both subcutaneously (5 males and 5 females) and intraperitoneally (10 males and
10 females) in Fl mice.
Serial intraperitoneal transplantation of this tumour was continued in Fl
hybrids. The tumour is now in its 16th transplant generation.
Control experiment. This consisted of the intraperitoneal injection of pooled
normal tissues from an A/Sn mouse into 10 male and 10 female Fl hybrids.
The tissue suspension was made up in the same way as the tumour suspensions
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and the same dose was used. The tissues used were liver, spleen, mammarygland
and red blood cells.
RESULTS
As shown in Table I the solid BA4 was carried for two transplant generatioiis
in Fl hybrids. It grew progressively and killed all 8 mice used, except those
used for transplantation. No sex differences in the tumour growth rate were
observed. Tumour from the second transplant generation transplanted sub-
cutaneously in Fl hybrids grew as before. The tumourtransplanted intraperitone-
ally also grew. Four weeks after transplantation all the males had markedly
distended abdomens while the females were macroscopically tumour free. One
of the males was killed and found to have extensive solid tumour growth in the
abdomen and some 3 ml. of extremely blood-stained ascitic fluid. WVet prepara-
tions of this fluid failed to reveal the presence of tumour cells. The fluid also
failed to give tumour growth on transplantation.
The second male mouse was then killed. This mouse showed only a knob of
solid tumour about 1 cm. in diameter. This tumour lay around the injection site
as could be verified histologically (Fig. 3). On its peritoneal side the tumour was
partly covered by the shiny peritoneum but part of its surface was dull. On
section (Fig. 4) it was seen that the peritoneal covering was missing in this area.
Histologically the solid tumour retained its original anaplastic form. V'ery little
stroma was present. At the eroded edge of the tumour it was possible to finld
areas where the stromal response was completely lacking. These areas had
been invaded by host macrophages and lymphocytes. Some of these areas
appeared to be cystic, others bounded directly onto the peritoneal cavity. From
these ragged surfaces free tumour cells could be seen mingling with the cells of the
host's inflammatory exudate.
In addition to the solid tumour this mouse contained 7 ml. of blood-stailned
ascitic fluid. Wet preparations showed that this fluid contained an abundance
of free tumour cells (Fig. 2).
The remaining male mice died within the next 3 weeks and all showed solid
tumour and haemorrhagic ascites containing an occasional tumour cell.
The 5 female mice first showed evidence of solid intraperitoneal growth 7
weeks after the injection of the tumour-saline suspension. All but one died
within the next 4 weeks and showed massive solid tumour but minimal ascites
formation. The exception remained tumour-free.
The haemorrhagic ascitic fluid from the second male mouse of the third
transplant generation that contained many tumour cells was transplanted
further in Fl mice, both subcutaneously and intraperitoneally. The tumour
grew progressively and killed all the mice used. The tumours growing sub-
cutaneously were indistinguishable histologically from the original solid anaplastic
carcinoma. All intraperitoneal inoculations resulted in the formation of an
ascitic tumour (Fig. 5) containing variable amounts of blood (Fig. 6). There
was a statistically significant negative correlation between the tumour blood
content and the host's survival time (r = -051).
No sex differences in tumour growth were seen in this (the fourth) transplanit
generation.
Serial intraperitoneal transplantation of the tumour in its ascitic form in
Fl hybrids has shown that the tumour blood content has continued to vary from
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mouse to mouse, and the negative correlation between the survival time and the
tumour blood content continues to hold.
Control experiment.-These mice showed no evidence of ascites formation.
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FIG. 6.-The blood content of the BA4 ascitic tumour related to the survival time of the mice
following intraperitoneal injection.
DISCUSSION
The finding that the formation of an ascites carcinoma is accompanied by a
haemorrhagic reaction is not new. The fact was established beyond doubt by
Klein in 1951. He transplanted a series of solid tumours intraperitoneally in
inbred mice, or their Fl hybrids, after mashing the tumour tissue in saline.
Out of eight established transplantable tumours he used, four mammary
carcinomas gave grossly haemorrhagic exudates in the peritoneal cavity, as did
one hepatoma, one melanoma, one neuroblastoma, and five (originally induced)
sarcomas. One hepatoma and one sarcoma gave no exudate at all. He also
used four spontaneous (i.e. not previously transplanted) mammary carcinomas-
EXPLANATION OF PLATE
FIG. 1.-The BA4 solid spontaneous anaplastic mammary carcinoma. H. and E x 112.
FIG. 2.-Source of BA4 ascitic tumour; the haemorrhagic exudate containing tumour cells
from male mouse of transplant generation 3. (Arrows mark tumour cells.). Leishman's
stain. x 180.
FIG. 3.-Solid BA4 tumour in male mouse of 3rd transplant generation that provided the
haemorrhagic exudate from which the BA4 ascitic tumour was derived. (Note tumour
on each side of abdominal musculature.) H. and E. x 105.
FIG. 4.-Eroded edge of BA4 tumour in mouse of transplant generation 3 that was the source
of the BA4 ascitic tumour. H. and E. x 105.
FIG. 5.-The BA4 ascitic tumour. Leishman's stain. x 180.BRITISH JOURNAL OF CANCER. Vol. XVIII, No. 3.
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all these gave haemorrhagic exudates. (Klein also used four lymphomas but,
as their behaviour appears to put them in a separate class, they will not be dis-
cussed here.)
The tumour cell content of these haemorrhagic exudates varied from 0-10
per cent. The subsequent establishment of an ascitic tumour was not entirely
dependent on the presence ofmany tumour cells in the first transplant generations.
However, the striking fact emerges that in the absence of a haemorrhagic reaction
ascites tumour formation was not established, while in its presence it was
common, with both carcinomas and sarcomas.
Klein's (1951) results also showed that it is easier to produce an ascitic tumour
from an established transplantable tumour than from a previously untransplanted
spontaneous tumour. Therefore in the present experiment the BA4 was propa-
gated subcutaneously before any attempt was made to induce an ascitic tumour.
Following the first intraperitoneal transplantation one of the mice was found
to have a haemorrhagic exudate that contained numerous tumour cells. This
fluid was transplanted subcutaneously and gave rise to tumours that were like
the original spontaneous tumour. On intraperitoneal transplantation an ascitic
tumour, as defined by Klein (1951), was produced in every case. Solid growth was
minimal and occurred only in late survivors, mainly as infiltration of the abdo-
minal wall and mesentery, as with the Ehrlich ascites carcinoma.
A further finding from the mice that had been given the first intraperitoneal
transplant of BA4 was a marked sex difference in the tumour growth rate and the
type of growth present. Sex differences in the growth of tumours are rare (Snell,
1953). As regards mammary carcinomas such a difference has been reported
once before (Foulds, 1947) in the growth of a tumour arising in an Fl hybrid,
which grew better in the females than in the males. A sex difference in the growth
of a carcinoma from inbred stock in its Fl hybrids does not appear to have been
reported previously. The difference observed here is the opposite of that observed
by Foulds as the tumour grew better in the males.
In the present case it is just possible that the tumour cell dose may have
differed in the two sexes. A 1 ml. syringe was used and was refilled, from the same
tumour suspension after remixing, after the injection of the females and before
the injection of the males. The homogeiiicity of the tumour-saline suspension
may not have been quite uniform and the removal of 1 ml. of the supernatant
could have caused an increase in the tumour cell content on resuspension. Thus
the males may have received a higher tumour cell dose. If so, this would be in
keeping with Klein's (1950) finding with the Ehrlich ascites carcinoma, that a
small dose may result in solid tumour formation while a large dose produces an
ascitic tumour. On the other hand, in his work with inbred strains (Klein, 1951)
he showed that the formation of an ascitic tumour is not dependent on the number
of tumour cells injected but on the host reaction to the cells-i.e. the formation
of a haemorrhagic exudate (vide supra). If the males received the greater cell
dose as their tumour growth suggests, the finding that the larger tumours
were accompanied by a greater haemorrhagic reaction is not surprising in view
of the previous finding, with the Ehrlich ascites carcinoma, that a higher tumour
cell dosage gives a greater haemorrhagic response (Hartveit, 1963).
In all events the males produced the haemorrhagic exudate. In one of them
the exudate contained many tumour cells. These tumour cells appeared to come
from areas of solid tumour that had outgrown the stromal response. The host
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inflammatory cells are probably secondary, but may have played a part in breaking
up the solid tumour.
The ascitic tumour produced following the injection of this exudate was mar-
kedly haemorrhagic. This finding cainot be attributed to a homograft reaction
as the tumour was transplanted in genetically compatible mice (Snell 1953).
Theoretically these Fl mice are not capable of rejecting any tumour arising in
their inbred parent (Billingham, Brent and Medawar, 1956). But the mice did
react against the tumour transplant. They all developed ascites and haemor-
rhage. This reaction was produced in response to tumour tissue, but not to normal
tissue, from a genetically compatible mouse. So in this case the mice must be
reacting against some factor in the tumour tissue that is not present in their
normal tissues.
This suggests that the tumour tissue may contain a tumour specific antigen
against which the mice that are otherwise genetically compatible could react.
It might be argued that this does not show that the tumour specific antigen was
present from the time the tumour arose. It may be the result of genetic change
that has taken place during serial transplantation. But even so, it would still
be a tumour specific antigen. Whether or not the acquisition of tumour specific
antigen has anything to do with malignant change is not known. It may be the
result, rather than the cause of malignant transformation.
As pointed out above, this is not the first time a haemorrhagic ascitic tumour
has arisen on transplantation of a tumour in genetically compatible stock.
Klein's (1951) findings add support to this report. So it is unlikely that this is a
chance observation brought about by faulty inbreeding or some such error in
technique.
The finding that the blood content of the tumour varies in the Fl mice is to
be expected as one of the parents was of inon-inbred stock and as phenotypic
variation may also play its part in the reaction.
Klein (1951) has reported that the tendency to haemorrhage in his ascitic
tumours decreased on further transplantation. On the other hand, he noted in
the same paper that occasional haemorrhagic tumours continued to occur. The
findings in the present case are in keeping with his second observation. The
blood content has, in all transplant generations to date, continued to show the
negative correlation to the survival time ofthe mouse that is also so characteristic
of the Ehrlich ascites carcinoma (Hartveit, 1961).
These observations stress that ascitic tumour growth is dependent on the
host's reaction to the tumour. This reaction appears to be dependent on the
presence of tumour specific antigen. The host's recognition of this " foreign "
antigen triggers off an inflammatorv reaction that leads to the production of an
ascitic tumour. The mechanism of this inflammatory reaction is at present
under investigation at this Institute.
SUtMMARY
A new ascitic tumour, the BA4, that arose as a spontaneous mammary carci-
noma in a female mouse ofA/Sn stock is described. This tumour, on transplanta-
tion in genetically compatible mice, gave rise to haemorrhagic ascitic tumours.
In the liglht ofthe fact that the tumourwas transplanted in genetically compatible
mice, and that bleeding into the Ehrlich ascites carcinoma was considered, on
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the basis of the author's previous work, to be an expression of genetic incompati-
bility, this finding suggests that a tumour specific antigen may be responsible
for the haemorrhage in this case.
A sex difference in tumour growth was also demonstrated-but could not be
upheld with any certainty.
I would like to thank Professor E. Waaler, Head of the Gade Institute, for
his advice and interest in this work.
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